Skip to NavigationSkip to content

Pharmafile - Research and Development News

Phase II trials will cover HER2-positive patients with metastatic or inflammatory breast cancer
Includes updates from CTA/Clininvent, BioClinica and MakroCare/LSK Global and US clinical trial regulation plans
Research into cancer, diabetes and heart disease among the activities to benefit
GlaxoSmithKline
Autifony will develop pharmacological treatments for hearing loss
Includes updates from Criterium, Eurofins Optimed/Spaulding, Synexus and Covance
Pays £4.6m for UK chemistry services firm
GlaxoSmithKline
In a phase III trial IPX066 performed better than standard treatment
MannKind's drug back in the running for approval after FDA passes new study design
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches